Caribou Biosciences, Inc.
CRBU- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001619856
No open-market purchases or sales by Caribou Biosciences, Inc. insiders were filed in the last 90 days; 137 institutions reported holding it in 13F filings for Q2 2026, worth $84.8M in total; Maverick Capital is the only superinvestor holding it.
13F holders, Q3 2023
Institutional positions in Caribou Biosciences, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 126
- +7 vs. Q2 2023
- Shares held
- 70.8M
- +29.4M (+71.1%) vs. Q2 2023
- Total value
- $338.5M
- +$163.1M (+93.0%) vs. Q2 2023
- New holders
- 28
- 58 more added
- Sold out
- 21
- 19 more reduced
2 institutions that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CRBU on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 137 | $84.8M |
| Q1 2026 | 137 | $71.3M |
| Q4 2025 | 124 | $58.8M |
| Q3 2025 | 117 | $87.0M |
| Q2 2025 | 129 | $51.2M |
| Q1 2025 | 131 | $45.8M |
| Q4 2024 | 133 | $93.1M |
| Q3 2024 | 129 | $103.1M |
| Q2 2024 | 140 | $87.6M |
| Q1 2024 | 151 | $343.0M |
| Q4 2023 | 144 | $395.8M |
| Q3 2023 | 126 | $338.5M |
| Q2 2023 | 121 | $185.5M |
| Q1 2023 | 126 | $238.3M |
| Q4 2022 | 133 | $273.8M |
| Q3 2022 | 113 | $456.8M |
| Q2 2022 | 120 | $203.0M |
| Q1 2022 | 104 | $313.2M |
| Q4 2021 | 93 | $464.7M |
| Q3 2021 | 88 | $704.7M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Caribou Biosciences, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Gsa Capital Partners LLP | 10,734 | $51.0K | 0.00% | +10,734 | New |
| Advisor Group Holdings, Inc. | 10,086 | $48.2K | 0.00% | +6,036+149.0% | Added |
| Ameritas Investment Partners, Inc. | 7,487 | $35.8K | 0.00% | +3,542+89.8% | Added |
| Amalgamated Bank | 7,226 | $35.0K | 0.00% | +1,516+26.5% | Added |
| Tower Research Capital LLC (TRC) | 7,256 | $34.7K | 0.00% | +385+5.6% | Added |
| GWM Advisors LLC | 7,200 | $34.4K | 0.00% | +1,000+16.1% | Added |
| Legal & General Group Plc | 6,194 | $29.6K | 0.00% | +684+12.4% | Added |
| Simplex Trading, LLC | 4,622 | $22.0K | 0.00% | −3,439−42.7% | Reduced |
| Metropolitan Life Insurance Co | 4,491 | $21.5K | 0.00% | +1,213+37.0% | Added |
| Lazard Asset Management LLC | 4,652 | $21.0K | 0.00% | +188+4.2% | Added |
| Citadel Advisors LLC | 2,989 | $14.3K | 0.00% | +868+40.9% | Added |
| National Bank of Canada | 2,444 | $11.0K | 0.00% | +1,113+83.6% | Added |
| China Universal Asset Management Co., Ltd. | 2,258 | $10.8K | 0.00% | +1,453+180.5% | Added |
| Newbridge Financial Services Group, Inc. | 2,000 | $9.56K | 0.00% | +2,000 | New |
| Nisa Investment Advisors, LLC | 1,060 | $5.07K | 0.00% | 00.0% | Unchanged |
| Harbour Investments, Inc. | 1,000 | $4.78K | 0.00% | +1,000 | New |
| Group One Trading, L.P. | 745 | $3.56K | 0.00% | −155−17.2% | Reduced |
| Federation des caisses Desjardins du Quebec | 500 | $2.39K | 0.00% | +500 | New |
| Lindbrook Capital, LLC | 269 | $1.29K | 0.00% | +269 | New |
| Piscataqua Savings Bank | 250 | $1.19K | 0.00% | 00.0% | Unchanged |
| US Bancorp | 241 | $1.15K | 0.00% | −20−7.7% | Reduced |
| Daiwa Securities Group Inc. | 176 | $1.00K | 0.00% | 00.0% | Unchanged |
| The PNC Financial Services Group, Inc. | 200 | $956 | 0.00% | −100−33.3% | Reduced |
| Jamison Private Wealth Management, Inc. | 188 | $899 | 0.00% | +188 | New |
| Farther Finance Advisors, LLC | 100 | $478 | 0.00% | 00.0% | Unchanged |
| TD Waterhouse Canada Inc. | 30 | $136 | 0.00% | 00.0% | Unchanged |
| Memorial Sloan Kettering Cancer Center | 0 | $0 | 0.00% | −544,196−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −436,024−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −162,221−100.0% | Sold out |
| Regents of the University of California | 0 | $0 | 0.00% | −90,652−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −83,612−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −77,467−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −44,155−100.0% | Sold out |
| UBS Asset Management Americas Inc | 0 | $0 | 0.00% | −32,062−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −39,350−100.0% | Sold out |
| Cornercap Investment Counsel Inc | 0 | $0 | 0.00% | −39,230−100.0% | Sold out |
| Public Employees Retirement System of Ohio | 0 | $0 | 0.00% | −37,700−100.0% | Sold out |
| Norges Bank | 0 | $0 | 0.00% | −24,800−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | 0 | $0 | 0.00% | −24,752−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −23,900−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −15,553−100.0% | Sold out |
| BSW Wealth Partners | 0 | $0 | 0.00% | −13,593−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −12,500−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −10,657−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −1,716−100.0% | Sold out |
| Venturi Wealth Management, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Sofos Investments, Inc. | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Pictet Asset Management SA | – | – | – | – | Not filed |
| Tekla Capital Management LLC | – | – | – | – | Not filed |